agilon health Management

Management criteria checks 3/4

agilon health's CEO is Steve Sell, appointed in Jun 2020, has a tenure of 4.42 years. total yearly compensation is $5.27M, comprised of 14.2% salary and 85.8% bonuses, including company stock and options. directly owns 0.022% of the company’s shares, worth $169.68K. The average tenure of the management team and the board of directors is 3.1 years and 6.1 years respectively.

Key information

Steve Sell

Chief executive officer

US$5.3m

Total compensation

CEO salary percentage14.2%
CEO tenure4.4yrs
CEO ownership0.02%
Management average tenure3.1yrs
Board average tenure6.1yrs

Recent management updates

Recent updates

agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Nov 10
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

agilon health Plunges On A Poor Prognosis (Rating Downgrade)

Nov 08

Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

Oct 15
Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

agilon health: Interesting Business Model, But Volatile And Uncertain

Aug 16

Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower

Aug 16
Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower

Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

Jul 15
Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More

Jun 06
The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More

agilon health: Still Not Healthy Enough To Warrant Upside

Apr 19

Is agilon health (NYSE:AGL) Using Too Much Debt?

Apr 04
Is agilon health (NYSE:AGL) Using Too Much Debt?

agilon health: High Growth But Unsustainable Economics

Nov 20

agilon health: Strong Sales Growth, Lacks Remaining Value Drivers

Sep 13

Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues

Jul 17
Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues

agilon health: A Hold Until Margins Are Improved

Jun 30

An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued

Jun 06
An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued

Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?

Apr 28
Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?

CEO Compensation Analysis

How has Steve Sell's remuneration changed compared to agilon health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$311m

Jun 30 2024n/an/a

-US$217m

Mar 31 2024n/an/a

-US$202m

Dec 31 2023US$5mUS$750k

-US$195m

Sep 30 2023n/an/a

-US$69m

Jun 30 2023n/an/a

-US$78m

Mar 31 2023n/an/a

-US$83m

Dec 31 2022US$6mUS$750k

-US$92m

Sep 30 2022n/an/a

-US$108m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

-US$391m

Dec 31 2021US$1mUS$750k

-US$384m

Sep 30 2021n/an/a

-US$387m

Jun 30 2021n/an/a

-US$363m

Mar 31 2021n/an/a

-US$69m

Dec 31 2020US$6mUS$433k

-US$63m

Compensation vs Market: Steve's total compensation ($USD5.27M) is above average for companies of similar size in the US market ($USD3.17M).

Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.


CEO

Steve Sell (58 yo)

4.4yrs

Tenure

US$5,267,036

Compensation

Mr. Steven Jackson Sell, also known as Steve, has been President and Chief Executive Officer at Agilon Health, Inc. since June 1, 2020 and also has been its Director since June 2020. Mr. Sell also serves a...


Leadership Team

NamePositionTenureCompensationOwnership
Steven Sell
President4.4yrsUS$5.27m0.022%
$ 169.7k
Jeffrey Schwaneke
Executive VP & CFOless than a yearUS$230.00k0.0077%
$ 60.4k
Girish Venkatachaliah
Chief Technology Officer3.8yrsUS$2.88m0.0033%
$ 25.8k
Benjamin Shaker
Chief Markets Officer4.2yrsUS$2.93m0.055%
$ 428.2k
Timothy Gertsch
VP, Controller & Chief Accounting Officer2.6yrsno data0.014%
$ 109.5k
Leland Thomas
Senior Manager of Investor Relationsno datano datano data
Denise Zamore
Chief Legal Officer & Secretary2.3yrsno datano data
Claire Mulhearn
Chief Communications & Public Affairs Officer3.3yrsno datano data
Mat Varghese
Chief People Officer3.1yrsno datano data
Bill Farry
Chief of Technology Innovationno datano datano data
Kenny Bellendir
Markets Chief Financial Officerno datano datano data
Kevin Spencer
Chief Clinical Officerless than a yearno datano data

3.1yrs

Average Tenure

48yo

Average Age

Experienced Management: AGL's management team is considered experienced (3.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Steven Sell
President4.4yrsUS$5.27m0.022%
$ 169.7k
Ronald Williams
Chairman of the Board7.8yrsUS$160.00k0.87%
$ 6.7m
Ravi Sachdev
Vice Chairman of the Board7.8yrsno datano data
Sharad Mansukani
Independent Director7.8yrsUS$245.00k0.30%
$ 2.3m
Silvana Battaglia
Independent Director1.4yrsUS$374.85k0.0022%
$ 17.0k
Diana McKenzie
Independent Director1.8yrsUS$405.44k0.0016%
$ 12.7k
Karen McLoughlin
Independent Director3.3yrsUS$292.50k0.0039%
$ 30.3k
John Wulf
Independent Director7.8yrsUS$230.00k0.031%
$ 243.8k

6.1yrs

Average Tenure

58.5yo

Average Age

Experienced Board: AGL's board of directors are considered experienced (6.1 years average tenure).